HCmed Innovations CoTPE:6934 -2.16%11 ROA % is 6.99% as of Dec. 2025. GuruFocus rates TPE:6934 with a GF Score™ of 11/100. The stock has 4 warning signs investors should review. Among 856 Medical Devices & Instruments companies, HCmed Innovations Co ranks worse than 64.84% on this metric.
ROA % is calculated as Net Income divided by its average Total Assets over a certain period of time. HCmed Innovations Co's annualizedNet Income for the quarter that ended in Dec. 2025 was NT$27.81 Mil.
HCmed Innovations Co's average Total Assets over the quarter that ended in Dec. 2025 was NT$397.92 Mil. Therefore, HCmed Innovations Co's annualized ROA % for the quarter that ended in Dec. 2025 was 6.99%.
The historical rank and industry rank for HCmed Innovations Co's ROA % or its related term are showing as below:
TPE:6934'
s ROA % Range Over the Past 10 Years
Min: -97.23 Med: -45.08 Max: -8.26
Current: -8.26
During the past 5 years, HCmed Innovations Co's highest ROA % was -8.26%. The lowest was -97.23%. And the median was -45.08%.
TPE:6934's ROA % is ranked worse than 64.84% of 856
companies
in the Medical Devices & Instruments industry
Industry Median: 0.545
vs TPE:6934: -8.26
HCmed Innovations Co (TPE:6934) ROA % Explanation
ROA % measures the rate of return on the total assets (shareholder equity plus liabilities). It measures a firm's efficiency at generating profits from shareholders' equity plus its liabilities. ROA % shows how well a company uses what it has to generate earnings. ROA %s can vary drastically across industries. Therefore, ROA % should not be used to compare companies in different industries. For retailers, a ROA % of higher than 5% is expected. For example, Wal-Mart (WMT) has a ROA % of about 8% as of 2012. For banks, ROA % is close to their interest spread. A banks ROA % is typically well under 2%.
Similar to ROE, ROA % is affected by profit margins and asset turnover. This can be seen from the Du Pont Formula:
Note:
The Net Income data used here is four times the quarterly (Dec. 2025) net income data. The Revenue data used here is four times the quarterly (Dec. 2025) revenue data.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Like ROE, ROA % is calculated with only 12 months data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. ROA % can be affected by events such as stock buyback or issuance, and by goodwill, a company's tax rate and its interest payment. ROA % may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high ROA % may indicate vulnerability in the durability of the competitive advantage.
E.g. Raising $43b to take on KO is impossible, but $1.7b to take on Moody's is. Although Moody's ROA % and underlying economics is far superior to Coca Cola, the durability is far weaker because of lower entry cost.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, HCmed Innovations Co's ROA %, along with its competitors' market caps and ROA % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
HCmed Innovations Co ROA % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, HCmed Innovations Co's ROA % distribution charts can be found below:
* The bar in red indicates where HCmed Innovations Co's ROA % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual ROA %, the net income of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is four times the quarterly (Dec. 2025) net income data.
ROA % is displayed in the 30-year financial page.
HCmed Innovations Co (TPE:6934) has a ROA % of 6.99% as of Dec. 2025. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on HCmed Innovations Co and its competitors. According to the industry distribution chart, HCmed Innovations Co ranks #555 out of 856 companies in the Medical Devices & Instruments industry, placing it in the top 64.8%.
Is HCmed Innovations Co's ROA % too high?
HCmed Innovations Co's current ROA % is 6.99%. The Medical Devices & Instruments industry median ROA % is 0.55. HCmed Innovations Co's value of 6.99% is 1182.6% above this industry median. Based on the distribution chart, HCmed Innovations Co ranks #555 out of 856 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, HCmed Innovations Co has a GF Score™ of 11/100, reflecting its overall financial health beyond just this single metric.
How does HCmed Innovations Co's ROA % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, HCmed Innovations Co ranks #555 out of 856 companies for ROA %. This places HCmed Innovations Co in the lower half of its industry. The industry median ROA % is 0.55. HCmed Innovations Co's value of 6.99% is 1182.6% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROA % for a Medical Devices & Instruments company?
The median ROA % among Medical Devices & Instruments companies is 0.55, based on 856 companies in the industry. Companies in the top quartile (top 25%) have a ROA % significantly above this median, while those in the bottom quartile fall well below. However, ROA % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. HCmed Innovations Co's current ROA % of 6.99% is 1182.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROA % mean?
A high ROA % can signal that a stock is expensive relative to its fundamentals. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on HCmed Innovations Co and its competitors. For the Medical Devices & Instruments industry, the median ROA % is 0.55 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. HCmed Innovations Co's current ROA % is 6.99%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is HCmed Innovations Co stock overvalued right now?
HCmed Innovations Co (TPE:6934) has a current ROA % of 6.99%. The current ROA % is 6.99% and 1182.6% above the Medical Devices & Instruments industry median of 0.55. HCmed Innovations Co's overall GF Score™ is 11/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROA % calculated?
ROA % is calculated from a company's financial statements. For HCmed Innovations Co (TPE:6934), the current ROA % is 6.99% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
HCmed Innovations Co Ltd is engaged in designing, developing, manufacturing and selling drug delivery system. It is focused on inhalation therapy to create integrated drug nebulizer combination products featuring nebulization therapeutic drugs that include small molecule synthetics and large molecule biologics, as either solutions, suspensions, and even difficult-to-deliver high viscosity drugs. Its product includes Pulmogine. Geographically, the company operates in America, Europe, Asian and African regions.
11GF Score
Get the complete analysis for TPE:6934
ROA % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TPE:6934 has been successfully added to your 
